Table 2. Participant demographics.
| Mean, SD | Range | ||
| Age | 72.38 | 53–85 | |
| Years since Diagnosis | 9.14 | 3–20 | |
| Age of Participants in larger TheraP Trial (intention to treat population) | Lutetium | 71.7 | |
| Cabazitaxel | 71.5 | ||
| Variable | Number* | Variable | Number |
| TheraP Treatment Arm | Marital Status | ||
| Lutetium (total n = 99) | 10 | Single | 3 |
| Cabazitaxel (total n = 101) | 5 | Married | 9 |
| Residency | Widowed | 1 | |
| Queensland | 8 | Divorced | 1 |
| Victoria | 6 | Previous Treatment | |
| Education | Hormone Therapy | 14 | |
| Low Level | 4 | Chemotherapy | 12 |
| Medium Level | 3 | Radiation Therapy | 8 |
| High Level | 4 | Radical Prostatectomy | 4 |
| Occupation | |||
| Employed | 1 | ||
| Unemployed | 1 | ||
| Retired | 10 |
*Missing data due to attrition and/or participants not returning the demographic questionnaire
*Previous treatment includes multiple received by participants